Galedra
Sign in Sign up

Evidence item

The primary passage directly supports the healthy UK sample and in-vitro proliferative-cell percentage endpoint. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 25325

Source: NeuroFit randomized trial in healthy middle-aged UK adults · locator {} · excerpt hash sha256:e591e4a94a56f66d56611bd8078d17a8f7d45ebc143c74b7ef64317e4bb48708

Exact excerpt
We conducted a three-month randomised controlled trial in healthy middle-aged adults in the UK (n = 52) ... significant intervention-by-time effects were detected ... for the percentage of proliferative cells in vitro.

Linked claims

ClaimDirectionRelevanceStepsCounted
f098784fSUPPORTDIRECT0yes

Audits

None.